檢索結果 - Dong Hoon Suh

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
    Metformin against Cancer Stem Cells through the Modulation of Energy Metabolism: Special Considerations on Ovarian Cancer

    Metformin against Cancer Stem Cells through the Modulation of Energy Metabolism: Special Considerations on Ovarian Cancer 由 Tae Hun Kim, Dong Hoon Suh, Mi‐Kyung Kim, Yong Sang Song

    出版 2014
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Mitochondrial permeability transition pore as a selective target for anti-cancer therapy

    Mitochondrial permeability transition pore as a selective target for anti-cancer therapy 由 Dong Hoon Suh, Mi-Kyung Kim, H. S. Kim, Hyun Hee Chung, Yong Sang Song

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Unfolded protein response to autophagy as a promising druggable target for anticancer therapy

    Unfolded protein response to autophagy as a promising druggable target for anticancer therapy 由 Dong Hoon Suh, Mi‐Kyung Kim, Hee Seung Kim, Hyun Hoon Chung, Yong Sang Song

    出版 2012
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Systematic Lymphadenectomy for Survival in Patients with Endometrial Cancer: A Meta-analysis

    Systematic Lymphadenectomy for Survival in Patients with Endometrial Cancer: A Meta-analysis 由 H. S. Kim, Dong Hoon Suh, M.-K. Kim, Hyunsook Chung, N. H. Park, Yong Sang Song

    出版 2012
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    Major clinical research advances in gynecologic cancer in 2021

    Major clinical research advances in gynecologic cancer in 2021 由 Jeong‐Yeol Park, Jung‐Yun Lee, Yoo-Young Lee, Seung‐Hyuk Shim, Dong Hoon Suh, Jae‐Weon Kim

    出版 2022
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015

    Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015 由 Myong Cheol Lim, Young‐Joo Won, Mun Jung Ko, Miseon Kim, Seung‐Hyuk Shim, Dong Hoon Suh, Jae‐Weon Kim

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Major clinical research advances in gynecologic cancer in 2018

    Major clinical research advances in gynecologic cancer in 2018 由 Miseon Kim, Dong Hoon Suh, Kyung-Hun Lee, Keun‐Yong Eom, Nanna Gilliam Toftdahl, Mansoor Raza Mirza, Jae‐Weon Kim

    出版 2019
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  8. 8
    PGC1α induced by reactive oxygen species contributes to chemoresistance of ovarian cancer cells

    PGC1α induced by reactive oxygen species contributes to chemoresistance of ovarian cancer cells 由 Boyun Kim, Je Won Jung, Jaeyoung Jung, Youngjin Han, Dong Hoon Suh, Hee Seung Kim, Danny N. Dhanasekaran, Yong Sang Song

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Gynecologic oncology in 2024: breakthrough trials and evolving treatment strategies for cervical, uterine corpus, and ovarian cancers

    Gynecologic oncology in 2024: breakthrough trials and evolving treatment strategies for cervical, uterine corpus, and ovarian cancers 由 Sung Jong Lee, Ji Geun Yoo, Jin Hwi Kim, Jeong‐Yeol Park, Jung‐Yun Lee, Yoo-Young Lee, Dong Hoon Suh

    出版 2025
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  10. 10
    Efficacy and oncologic safety of nerve-sparing radical hysterectomy for cervical cancer: a randomized controlled trial

    Efficacy and oncologic safety of nerve-sparing radical hysterectomy for cervical cancer: a randomized controlled trial 由 Ju‐Won Roh, Dong Ock Lee, Dong Hoon Suh, Myong Cheol Lim, Sang‐Soo Seo, Jinsoo Chung, Sun Lee, Sang‐Yoon Park

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort Study

    Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort Study 由 Hee Seung Kim, Hwa-Young Choi, Maria Lee, Dong Hoon Suh, Kidong Kim, Jae Hong No, Hyun Hoon Chung, Yong Beom Kim, Yong Sang Song

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3

    Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3 由 Jung‐Yun Lee, Yoo-Young Lee, Jeong‐Yeol Park, Seung‐Hyuk Shim, Se Ik Kim, Tae‐Wook Kong, Chul Kwon Lim, Hyun‐Woong Cho, Dong Hoon Suh

    出版 2023
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  13. 13
    Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture

    Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture 由 Dong Hoon Suh, Tae Hun Kim, Jae‐Weon Kim, Sun Young Kim, Hee Seung Kim, Taek Sang Lee, Hyun Hoon Chung, Yong-Beom Kim, Noh Hyun Park, Yong Sang Song

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study

    Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospectiv... 由 Eun Jung Yang, A Jin Lee, Woo Yeon Hwang, Suk‐Joon Chang, Hee Seung Kim, Nam Kyeong Kim, Yeorae Kim, Tae‐Wook Kong, Eun Ji Lee, Soo Jin Park, Joo‐Hyuk Son, Dong Hoon Suh, Dong Hee Son, Seung‐Hyuk Shim

    出版 2024
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: